STOCK TITAN

Top 100 Stocks by R&D Spending

Top companies ranked by R&D spending, latest annual filings.

What R&D Spending Means for US-listed Companies

R&D spending is the dollars a company puts into research, engineering, and product development each year. Under US GAAP most of it is expensed immediately rather than capitalized, so the outlay lands on the income statement in the year it is incurred and suppresses current earnings even when the work is building assets that will pay off over many future periods. Disclosure quality varies sharply across industries.

Why R&D Spending Matters

Sustained R&D is often what separates firms with a durable competitive moat from those slowly losing share to better-funded rivals, because patent pipelines, platform expansion, and technology leadership are cumulative. Still, R&D spending is not R&D productivity; two firms can commit similar dollars and produce very different pipelines. Timing also distorts cross-sector comparisons, since spike years on major programs look different from steady maintenance budgets.

What to Read Alongside

Read R&D alongside Revenue to gauge innovation intensity as a share of sales, Net Income to see how heavily expensing pressures earnings, and Free Cash Flow since R&D-heavy firms often show lower cash conversion.

Data as of FY 2025 100 companies Rhea AI
# Symbol Company Sector
1 GOOG Alphabet Inc. Communication Services $61.09B $3.41T
2 META Meta Platforms, Inc. Communication Services $57.37B $1.58T
3 AAPL Apple Inc. Technology $45.77B $5.11T
4 MSFT Microsoft Corporation Technology $35.56B $3.76T
5 NVDA NVIDIA Corporation Technology $18.50B $3.75T
6 MRK Merck & Co., Inc. Healthcare $15.79B $353.44B
7 JNJ Johnson & Johnson Healthcare $14.66B $670.92B
8 AZN AstraZeneca PLC Healthcare $14.23B $282.69B
9 INTC Intel Corporation Technology $13.77B $293.23B
10 LLY Eli Lilly and Company Healthcare $13.34B $1.26T
11 NVS Novartis AG Healthcare $11.20B $300.54B
12 AVGO Broadcom Inc. Technology $10.98B $1.63T
13 PFE Pfizer Inc. Healthcare $10.44B $162.27B
14 ORCL Oracle Corporation Technology $10.27B $358.54B
15 QCOM QUALCOMM Incorporated Technology $10.21B $178.34B
16 GSK GSK plc Healthcare $10.12B $98.70B
17 BMY Bristol-Myers Squibb Company Healthcare $9.95B $125.40B
18 TM Toyota Motor Corporation Consumer Cyclical $9.86B $250.12B
19 HMC Honda Motor Co., Ltd. Consumer Cyclical $9.68B $43.89B
20 BABA Alibaba Group Holding Limited Consumer Cyclical $9.65B $215.56B
21 CSCO Cisco Systems, Inc. Technology $9.56B $374.45B
22 F Ford Motor Company Consumer Cyclical $9.40B $45.28B
23 SNY Sanofi Healthcare $9.20B $114.13B
24 ABBV AbbVie Inc. Healthcare $9.10B $517.59B
25 IBM International Business Machines Corporation Technology $8.32B $218.41B
26 NVO Novo Nordisk A/S Healthcare $8.18B $179.38B
27 AMD Advanced Micro Devices, Inc. Technology $8.09B $833.18B
28 TSM Taiwan Semiconductor Manufacturing Company Limited Technology $7.86B $1.87T
29 SAP SAP SE Technology $7.78B $256.82B
30 AMGN Amgen Inc. Healthcare $7.27B $247.70B
31 TSLA Tesla, Inc. Consumer Cyclical $6.41B $1.50T
32 CRM Salesforce, Inc. Technology $5.99B $160.09B
33 REGN Regeneron Pharmaceuticals, Inc. Healthcare $5.85B $99.08B
34 GILD Gilead Sciences, Inc. Healthcare $5.80B $211.18B
35 NOK Nokia Oyj Technology $5.70B $42.95B
36 MU Micron Technology, Inc. Technology $5.65B $806.05B
37 ASML ASML Holding N.V. Technology $5.51B $533.08B
38 ERIC Telefonaktiebolaget LM Ericsson (publ) Technology $5.30B $33.43B
39 SONY Sony Group Corporation Technology $4.79B $155.50B
40 TAK Takeda Pharmaceutical Company Limited Healthcare $4.25B $69.14B
41 VRTX Vertex Pharmaceuticals Incorporated Healthcare $3.91B $135.44B
42 BA The Boeing Company Industrials $3.62B $129.89B
43 AMAT Applied Materials, Inc. Technology $3.57B $277.15B
44 UBER Uber Technologies, Inc. Technology $3.40B $140.50B
45 NFLX Netflix, Inc. Communication Services $3.39B $245.07B
46 INTU Intuit Inc. Technology $3.38B $85.73B
47 TEAM Atlassian Corporation Technology $3.27B $35.51B
48 JD JD.com, Inc. Consumer Cyclical $3.18B $34.34B
49 DELL Dell Technologies Inc. Technology $3.14B $205.23B
50 MRNA Moderna, Inc. Healthcare $3.13B $83.68B
51 NOW ServiceNow, Inc. Technology $2.96B $96.42B
52 ABT Abbott Laboratories Healthcare $2.94B $181.35B
53 BIDU Baidu, Inc. Communication Services $2.92B $24.22B
54 XYZ Block, Inc. Technology $2.91B $47.94B
55 MDT Medtronic plc Healthcare $2.87B $130.88B
56 RTX RTX Corporation Industrials $2.81B $267.19B
57 ARM Arm Holdings plc Technology $2.78B $196.23B
58 WDAY Workday, Inc. Technology $2.68B $44.05B
59 PANW Palo Alto Networks, Inc. Technology $2.55B $253.24B
60 NTES NetEase, Inc. Communication Services $2.53B $76.59B
61 HPE Hewlett Packard Enterprise Company Technology $2.52B $61.18B
62 SNPS Synopsys, Inc. Technology $2.48B $83.46B
63 BNTX BioNTech SE Healthcare $2.47B $21.04B
64 LRCX Lam Research Corporation Technology $2.38B $263.66B
65 NXPI NXP Semiconductors N.V. Technology $2.36B $63.65B
66 PDD PDD Holdings Inc. Consumer Cyclical $2.36B $110.16B
67 ABNB Airbnb, Inc. Consumer Cyclical $2.35B $106.31B
68 DE Deere & Company Industrials $2.31B $175.05B
69 MELI MercadoLibre, Inc. Consumer Cyclical $2.27B $72.84B
70 TCOM Trip.com Group Limited Consumer Cyclical $2.16B $27.46B
71 CAT Caterpillar Inc. Industrials $2.15B $261.19B
72 ONC BeOne Medicines AG Healthcare $2.15B $47.21B
73 PG The Procter & Gamble Company Consumer Defensive $2.10B $398.01B
74 TXN Texas Instruments Incorporated Technology $2.08B $270.35B
75 MRVL Marvell Technology, Inc. Technology $2.08B $133.83B
76 BSX Boston Scientific Corporation Healthcare $2.05B $62.37B
77 INCY Incyte Corporation Healthcare $2.05B $24.27B
78 STM STMicroelectronics N.V. Technology $2.04B $39.51B
79 LMT Lockheed Martin Corporation Industrials $2.00B $136.37B
80 PHG Koninklijke Philips N.V. Healthcare $2.00B $29.22B
81 SNOW Snowflake Inc. Technology $1.97B $96.29B
82 HON Honeywell International Inc. Industrials $1.81B $69.49B
83 SNAP Snap Inc. Communication Services $1.79B $9.50B
84 BIIB Biogen Inc. Healthcare $1.78B $37.07B
85 ADI Analog Devices, Inc. Technology $1.77B $185.91B
86 COIN Coinbase Global, Inc. Financial Services $1.67B $30.45B
87 RIVN Rivian Automotive, Inc. Consumer Cyclical $1.67B $17.34B
88 ADSK Autodesk, Inc. Technology $1.64B $53.34B
89 EBAY eBay Inc. Consumer Cyclical $1.64B $52.06B
90 SPOT Spotify Technology S.A. Communication Services $1.63B $123.73B
91 SYK Stryker Corporation Healthcare $1.62B $120.88B
92 LI Li Auto Inc. Consumer Cyclical $1.62B $11.31B
93 GMAB Genmab A/S Healthcare $1.61B $32.04B
94 HPQ HP Inc. Technology $1.60B $25.89B
95 DHR Danaher Corporation Healthcare $1.60B $158.84B
96 GE GE Aerospace Industrials $1.58B $338.66B
97 RBLX Roblox Corporation Communication Services $1.57B $31.49B
98 DDOG Datadog, Inc. Technology $1.55B $59.64B
99 SHOP Shopify Inc. Technology $1.54B $182.56B
100 KLAC KLA Corporation Technology $1.53B $188.36B

How this ranking is built

Companies are ranked by R&D spending as reported in their most recent annual filing with the SEC. Figures shown are in US dollars (or percent, as noted), rounded to two decimals, and a company that files in another currency is ranked on its figures translated at the rate recorded for that period.

  • Source: annual 10-K / 20-F filings from companies trading on US exchanges (NYSE, Nasdaq, NYSE American, Texas Stock Exchange).
  • Fiscal year: whichever annual period the company has most recently filed. Fiscal years don't always align with the calendar year, so the "as of FY" stamp above reflects the most common year across the table.
  • Filtered out: warrants, preferred shares, and duplicate listings that share a parent company's financials.
  • Size floor: A company qualifies at $500 million in market cap or above. Below that, one mis-stated figure outranks the companies the list is about.
  • Currency check: A company whose annual revenue runs above 15 times its market cap is left out, because at that gap the two figures are not in the same currency.
  • Currency check: A company whose balance sheet runs above 150 times its market cap is left out for the same reason.
  • Market cap: stated at each company's latest close, which is newer than the annual figure ranked here.
  • Update cadence: refreshed as companies file new annual reports (typically within 60–90 days of fiscal year end).

Not financial advice. This is a research tool, not a recommendation.

Frequently asked questions

Why does R&D spending reduce reported earnings even when it builds long-term value?

US accounting rules require most research and development to be expensed in the period it is incurred, rather than capitalized and depreciated over the life of the resulting product. The logic is conservative: the future benefit is uncertain, so it would overstate assets to carry R&D on the balance sheet. The side effect is that a firm investing heavily in next-generation products can look less profitable than a peer harvesting an older portfolio, even if the long-term economics favor the investor.

Does a higher R&D figure mean a stronger innovation pipeline?

Not directly. Spending measures input, not output. Two firms can commit similar R&D dollars yet produce very different pipelines depending on research focus, execution quality, and the patience of management. Absolute dollars also favor larger firms by default, so the ratio of R&D to revenue often tells a more useful story about commitment to innovation than the raw total, and patent filings or product cadence add an independent check on how productive that spending actually is.

Why are some industries missing from R&D rankings?

Financial services, real estate, and parts of consumer retail tend not to disclose meaningful R&D, either because the expense category does not fit their activities or because equivalent spending appears under other lines such as technology investment or product development. The ranking therefore over-represents technology, healthcare, and parts of industrials where formal R&D disclosure is standard, and under-represents sectors where comparable innovation spending is real but reported differently.